Eradicating Barrett's Esophagus Using Radiofrequency Ablation or a Novel Hybrid Argon PlasmaCoagulation Technique
|Erbe USA, Incorporated
|Male and Female Patients
|U.S. Govt. ID:
|Research Nurse Navigator: 212-342-5162 / email@example.com
The purpose of the study is to compare two types of endoscopic treatments in patients with Barretts esophagus (BE) with abnormal cells (dysplasia); radiofrequency ablation (RFA) and hybrid argon plasma coagulation (H-APC). H-APC is a newer technique in the treatment of BE and has not been adequately studied and is not approved by the FDA for routine use. This study is being conducted to better understand how H-APC works in the treatment of BE and compare it to RFA treatment.
This study is closed
Julian Abrams, MD
|Are Are you between 18-85 years of age?
|Do you have a confirmed diagnosis of Barrett's Esophagus with abnormal cells (dysplastic)?
|Have you not received any prior ablative endoscopic treatment?